Cargando…
Risk-benefit ratio assessment for stroke prevention in intermediate risk atrial fibrillation patients: will TEE-based aspirin treatment fill the gap?
| Autores principales: | , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Bohn Stafleu van Loghum
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3087023/ https://www.ncbi.nlm.nih.gov/pubmed/21487742 http://dx.doi.org/10.1007/s12471-011-0119-z |
| _version_ | 1782202733130940416 |
|---|---|
| author | Smit, M. D. Van Gelder, I. C. |
| author_facet | Smit, M. D. Van Gelder, I. C. |
| author_sort | Smit, M. D. |
| collection | PubMed |
| description | |
| format | Text |
| id | pubmed-3087023 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2011 |
| publisher | Bohn Stafleu van Loghum |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-30870232011-06-06 Risk-benefit ratio assessment for stroke prevention in intermediate risk atrial fibrillation patients: will TEE-based aspirin treatment fill the gap? Smit, M. D. Van Gelder, I. C. Neth Heart J Editorial Bohn Stafleu van Loghum 2011-04-13 2011-05 /pmc/articles/PMC3087023/ /pubmed/21487742 http://dx.doi.org/10.1007/s12471-011-0119-z Text en © The Author(s) 2011 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
| spellingShingle | Editorial Smit, M. D. Van Gelder, I. C. Risk-benefit ratio assessment for stroke prevention in intermediate risk atrial fibrillation patients: will TEE-based aspirin treatment fill the gap? |
| title | Risk-benefit ratio assessment for stroke prevention in intermediate risk atrial fibrillation patients: will TEE-based aspirin treatment fill the gap? |
| title_full | Risk-benefit ratio assessment for stroke prevention in intermediate risk atrial fibrillation patients: will TEE-based aspirin treatment fill the gap? |
| title_fullStr | Risk-benefit ratio assessment for stroke prevention in intermediate risk atrial fibrillation patients: will TEE-based aspirin treatment fill the gap? |
| title_full_unstemmed | Risk-benefit ratio assessment for stroke prevention in intermediate risk atrial fibrillation patients: will TEE-based aspirin treatment fill the gap? |
| title_short | Risk-benefit ratio assessment for stroke prevention in intermediate risk atrial fibrillation patients: will TEE-based aspirin treatment fill the gap? |
| title_sort | risk-benefit ratio assessment for stroke prevention in intermediate risk atrial fibrillation patients: will tee-based aspirin treatment fill the gap? |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3087023/ https://www.ncbi.nlm.nih.gov/pubmed/21487742 http://dx.doi.org/10.1007/s12471-011-0119-z |
| work_keys_str_mv | AT smitmd riskbenefitratioassessmentforstrokepreventioninintermediateriskatrialfibrillationpatientswillteebasedaspirintreatmentfillthegap AT vangelderic riskbenefitratioassessmentforstrokepreventioninintermediateriskatrialfibrillationpatientswillteebasedaspirintreatmentfillthegap |